BURLINGTON, Vermont – June 25, 2024 – The International Academy on the Science and Impact of Cannabis (IASIC) released its official statement against the proposed rescheduling of Cannabis from Schedule I to Schedule III of the Controlled Substances Act:
As physicians and concerned citizens of the United States of America, the International Academy on the Science and Impact of Cannabis believes that re-scheduling will have immediate and irreparable harm to the public health and vehemently oppose the removal of cannabis from Schedule 1. Specific objections include (1) The Department of Health and Human Services (HHS) inappropriately changed the definition of currently acceptable medical use (CAMU); (2) Even under the new definition, cannabis still does not meet the requirements for CAMU; (3) Proper regulation of cannabis as a schedule 3 drug cannot be achieved while non-medical cannabis commerce is allowed.
“HHS and those who are pushing rescheduling of cannabis are unaware or ignoring the huge amount of science on the medical harms of cannabis. There is zero benefit and only problems to be had from rescheduling,” said Eric A. Voth, MD, FACP, President and Chairman of the Board, The International Academy on the Science and Impact of Cannabis.
An official request for a hearing with the DEA has been submitted by IASIC during the current open comment period, with its leadership urging the presentation of medical and scientific research from its physician-driven organization of international experts on cannabis.
IASIC has provided substantial education and background on the impending harm of the proposed rescheduling in its monthly speaker series on June 11th as well as on the High Truths on Drugs and Addiction podcast with episode #182: High Truths on Drugs and Addiction on Rescheduling of Marijuana with IASIC.
Delta-8 tetrahydrocannabinol, also known as delta-8 THC, is a psychoactive substance found in the Cannabis sativa plant, of which marijuana and hemp are two varieties. Delta-8 THC is one of over 100 cannabinoids produced naturally by the cannabis plant but is not found in significant amounts in the cannabis plant. As a result, concentrated amounts
State regulators say the Oregon manufacturer Select, also known as Cura Cannabis, mixed up two lines of products at its Portland manufacturing site. A CBD product was not supposed to contain THC, but bottles sold contained high levels of the psychoactive ingredient associated with marijuana. A THC product was sold without sufficient doses of THC.
State regulators say the Oregon manufacturer Select, also known as Cura Cannabis, evidently mixed up two lines of products at its Portland manufacturing site. A CBD product, at left, was not supposed to contain THC, but bottles sold contained high levels of the psychoactive ingredient associated with marijuana. A THC product, at right, was sold
CBD has over 500 drug interactions and side effects include liver damage and suicide risk. That is why FDA is stepping up warnings on CBD products. Consumer protection and Science is important. Visit the IASIC library to learn more about CBD and Drug interactions. Read the full article here: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cannafyl-611957-03012021
Dr. Phil and Dr. Oz discuss the wild west that is the CBD industry. To learn more about CBD visit the IASIC library. Watch it here: https://www.youtube.com/watch?v=Dncnf1mNTpA
The U.S. Food and Drug Administration objected to an application from Charlotte’s Web Holdings Inc. for a CBD product to be sold as a dietary ingredient, leaving a cloud of uncertainty over the booming industry for the cannabis-derived substance. View the full article here: https://fortune.com/2021/08/11/fda-cbd-dietary-supplement-charlottes-web-holdings/ IASIC commends the FDA to sticking to science. While CBD
New York has banned delta 8. Should your community do the same? https://www.syracuse.com/marijuana/2021/05/new-york-bans-hot-new-cannabis-product-delta-8-striking-a-blow-to-some-cbd-retailers.html
All marijuana is cannabis, but not all cannabis is marijuana. See original post here May 10, 2021 by Laura Stack By Laura Stack At Johnny’s Ambassadors, we educate parents and teens about the dangers of today’s high-THC marijuana on adolescent brain development, mental illness, and suicide. Recently, Johnny’s Ambassadors has been asked about our usage of the
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of
Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
